Canada · Funded startup

Who invested in Centre for Commercialization of Cancer Immunotherapy

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$3.4Mraised across 1 round since 2023, from 1 source

Latest round
Grant, $3.4MNov 2023
Investors
1
See who backed them

The rounds

  1. Nov 2023

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Centre for Commercialization of Cancer Immunotherapy

Who invested in Centre for Commercialization of Cancer Immunotherapy?

Centre for Commercialization of Cancer Immunotherapy's investors include Canada Economic Development for Quebec Regions.

How much has Centre for Commercialization of Cancer Immunotherapy raised?

Centre for Commercialization of Cancer Immunotherapy has raised $3.4M across 1 round since 2023.

When did Centre for Commercialization of Cancer Immunotherapy last raise?

Centre for Commercialization of Cancer Immunotherapy's most recent round was a Grant of $3.4M in Nov 2023.

What was Centre for Commercialization of Cancer Immunotherapy's biggest round?

Its most recent round, $3.4M in Nov 2023, is also its largest on record.

Who backed Centre for Commercialization of Cancer Immunotherapy first?

Centre for Commercialization of Cancer Immunotherapy's first round on record, in Nov 2023, was backed by Canada Economic Development for Quebec Regions.

What stage is Centre for Commercialization of Cancer Immunotherapy at?

Centre for Commercialization of Cancer Immunotherapy's latest named round is a Grant, in Nov 2023.

Where is Centre for Commercialization of Cancer Immunotherapy based?

Centre for Commercialization of Cancer Immunotherapy is based in Canada.

Companies like Centre for Commercialization of Cancer Immunotherapy

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.